Atorvastatin Therapy for the Prevention of Atrial Fibrillation (SToP-AF)

NCT00252967 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

64

Enrollment

OTHER

Sponsor class

Stopped Insufficient power to show therapy difference at interim analysis.

Conditions

Atrial Fibrillation
Inflammation

Interventions

DRUG: Atorvastatin
DRUG: Placebo

Sponsor

Emory University

Collaborators

[object Object]